Delivery Order HHSN272201500012I-HHSN27200009
Award Date
4/22/16
Potential Completion Date
5/22/16
Potential Value
$7.5K
Federal Agency
National Institute of Allergy and Infectious Diseases
Ultimate Awardee
Not listed
NAICS Category
541711 - Research and Development in Biotechnology
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
San Antonio, TX 78244, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
<p>This is a firm fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to Alpha Diagnostic International Inc., a minority-owned, woman-owned small business. The contract is for the provision of 96-test kits for a Human Anti-Zaire-Ebola Virus Glycoprotein (GP) IgG ELISA. The contract has a ceiling value of $146,525.00 and a period of performance ending on April 1, 2015. This contract does not have a set-aside designation.</p>
This is a firm fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a subcomponent of the U.S. Department of Health and Human Services (HHS), to Alpha Diagnostic International Inc., a minority-owned, woman-owned small business. The contract is for the provision of a human anti-Zaire Ebola virus glycoprotein (GP) IgG ELISA kit and low NSB diluent bottle. The contract has a ceiling value of $82,765.00 and a performance period ending on May 1,...
This federal contract award, with identifier HHSN272201500012I|HHSN27200003, was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency under the U.S. Department of Health and Human Services. The award was made to Alpha Diagnostic International Inc., a woman-owned small business, for the delivery of human anti-Zaire Ebola virus nucleoprotein (NP) IgG ELISA kits. The fixed-price contract has a ceiling value of $159,225.00 and a completion date of June 16,...
This federal contract award was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to Alpha Diagnostic International Inc., a minority-owned, woman-owned small business. The contract is for the delivery of an AMBIS #1743202 kit, which includes human anti-Zaire Ebola virus nucleoprotein (NP) IgG ELISA kits, 96 tests, and a low NSB diluent bottle. The contract has a firm fixed price of $5,544.50 and a completion date of June 16, 2016. The contract was...
This is a $10,495 firm fixed price delivery order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to Alpha Diagnostic International Inc., a minority-owned, woman-owned small business. The contract is for the procurement of 20 units of the AMBIS # 1768645 Human Anti-Zaire-Ebola Virus Glycoprotein (GP) IgM ELISA Kit at a unit price of $516.00. The contract has a completion date of June 16, 2016 and was awarded on December 4, 2015. This contract does not have a...
<p>This is a firm-fixed-price delivery order awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to Alpha Diagnostic International Inc., a woman-owned small business. The order is for the procurement of 12 bulk kits of the AMBIS # 1774444 Human Anti-Zaire Ebola Virus Glycoprotein (GP) IgG ELISA Kit, 96 tests quantitative. The total ceiling value of the award is $69,910.00, with a completion date of June 16, 2016. This award does not have a set-aside designation.</p>
<p>This is a firm fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the Department of Health and Human Services (HHS), to Alpha Diagnostic International Inc. for the delivery of human anti-Zaire Ebola virus glycoprotein (GP) IgG ELISA kits and low NSB diluent. The contract has a ceiling value of $82,765.00 and a period of performance that ended on May 19, 2016. The contract does not have a set-aside designation.</p>
This federal contract award, HHSN272201500396P, was made by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Alpha Diagnostic International Inc. for the provision of an "AMBIS NO. 1725132REAGENT - EBOLA VIRUS NP IGG ELISA KIT, QUANTITATIVE" with a ceiling value of $151,462.50. The contract is a firm-fixed-price purchase order with a completion date of March 26, 2015. Alpha Diagnostic International Inc. is a...
This is a federal contract award from the National Institute of Allergy and Infectious Diseases (NIAID), a division of the Department of Health and Human Services (HHS), to Alpha Diagnostic International Inc. The award, valued at $13,666.00, is for the procurement of an "AMBIS #1709226 HUMAN ANTI-ZAIRE-EBOLA VIRUS GLYCOPROTEIN (GP) IGG ELISA KIT". This is a firm fixed-price purchase order with a completion date of November 14, 2014. The contract does not have a set-aside designation.
<p>This federal contract award, valued at $13,390.00, was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. government. The contract was awarded to Alpha Diagnostic International Inc., a minority-owned, woman-owned small business, for the provision of proteins and antibodies. The contract is a firm fixed price purchase order with an ultimate completion date of August 5, 2016. There is no set-aside designation for this award.</p>